Latest News

Biden boosts LGBTQIA+ protections, bans conversion therapy


 

Guidance on starting transgender treatment

In other LGBTQIA+-related news, an international group focusing on transgender health lowered the minimum ages they recommend for starting hormone therapy or surgery for transgender youth.

The World Professional Association for Transgender Health said that hormones could be started at 14, 2 years earlier than the group’s previous advice. The association also said some surgeries can be performed at age 15 or 17, a year or so earlier than their previous recommendations.

The group acknowledged potential risks but said it is unethical and harmful to withhold early treatment, according to a report from The Associated Press.

Transgender treatment for teens has been a controversial issue, with experts disagreeing about whether teenagers can fully understand the ramifications of such life-altering decisions.

During the White House background media call, senior administration officials pointed to existing policy regarding transgender care. “We’ve already put out guidance through HHS about civil rights protections and making clear that the denial of medical care based on someone’s gender identity is discriminatory and have invited the members of the public to file complaints with the Office of Civil Rights.”

A version of this article first appeared on WebMD.com.

Pages

Recommended Reading

HHS prohibits discrimination against LGBTQ patients: Action reverses Trump-era policy
Federal Practitioner
The Cures Act: Is the “cure” worse than the disease?
Federal Practitioner
AAP ‘silencing debate’ on gender dysphoria, says doctor group
Federal Practitioner
To be, or not to be? More counseling needed for gender dysphoria
Federal Practitioner
Psychiatrists shift stance on gender dysphoria, recommend therapy
Federal Practitioner
Overview of guidelines for patients seeking gender-affirmation surgery
Federal Practitioner
FDA issues stronger safety requirements for breast implants
Federal Practitioner
The significance of Transgender Awareness Week
Federal Practitioner
Risk for severe COVID-19 and death plummets with Pfizer booster
Federal Practitioner
More medical schools build training in transgender care
Federal Practitioner